Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 14/20 | 0.44 |
| ▸ | RARB | P10826 | 11/20 | 0.44 |
| ▸ | RXRB | P28702 | 10/20 | 0.44 |
| ▸ | RARG | P13631 | 10/20 | 0.44 |
| ▸ | RXRG | P48443 | 6/20 | 0.44 |
| ▸ | RARA | P10276 | 7/20 | 0.42 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CRABP2 | P29373 | 1/20 | 0.41 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29707990 | 1.00 | RXRA (0.44) | RXRARARBRXRBRARGRXRG | |
| SCHEMBL9446453 | 0.86 | KDM4E (0.38) | RXRARARBRXRBRARGRXRG | |
| SCHEMBL24524497 | 0.81 | RARA (0.49) | RXRARARBRXRBRARGRXRG | |
| SCHEMBL28921096 | 0.80 | RARB (0.47) | RXRARARBRXRBRARGRXRG | |
| SCHEMBL13636819 | 0.79 | RARB (0.63) | RXRARARBRARGRARACYP26A1 | |
| SCHEMBL29549031 | 0.78 | BACE1 (0.33) | CYP3A4MEN1ALDH1A1MAPK1KMT2A | |
| SCHEMBL31534581 | 0.78 | KDM4E (0.36) | CYP3A4MEN1ALDH1A1TSHRKMT2A | |
| SCHEMBL11309510 | 0.78 | KDM4E (0.39) | MEN1ALDH1A1KMT2A | |
| SCHEMBL806947 | 0.78 | KDM4E (0.36) | CYP3A4MEN1ALDH1A1TSHRKMT2A | |
| SCHEMBL9326911 | 0.78 | BACE1 (0.33) | CYP3A4MEN1ALDH1A1MAPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552818-B2 | Polycyclic compounds for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2026-02-17 | — | — | US | disclosed |
| US-12435098-B2 | Heterocyclic compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2025-10-07 | — | — | US | disclosed |
| US-20250263429-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-08-21 | — | — | US | disclosed |
| US-20240360114-A1 | FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF | Sironax Ltd. (KY) | 2024-10-31 | — | — | US | disclosed |
| EP-3919500-B1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2024-08-28 | — | — | EP | disclosed |
| US-20240196735-A1 | Organic Compound, Organic Light Emitting Diode and Organic Light Emitting Device Having the Compound | LG DISPLAY CO., LTD. (US) | 2024-06-13 | — | — | US | disclosed |
| WO-2024071860-A1 | INK COMPOSITION, ORGANIC LIGHT-EMITTING DEVICE USING SAME, AND MANUFACTURING METHOD THEREFOR | 주식회사 엘지화학 | 2024-04-04 | — | — | WO | disclosed |
| EP-3909958-B1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2023-12-27 | — | — | EP | disclosed |
| EP-4273151-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | Lg Chem, Ltd. (KR) | 2023-11-08 | — | — | EP | disclosed |
| US-20230348399-A1 | NOVEL PYRIMIDINE DERIVATIVE AND USE THEREOF | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2023-11-02 | — | — | US | disclosed |
| EP-0410358-A1 | Aromatic carboxylic acid amides, their preparation and their use as medicines | F. HOFFMANN-LA ROCHE AG (CH) | 1991-01-30 | — | — | EP | disclosed |
| EP-0170105-B1 | BENZOIC ACID DERIVATIVES | Shudo, Koichi, Prof. Dr. (JP) | 1990-10-17 | — | — | EP | disclosed |
| EP-0386451-A1 | Oxygen-bearing diphenyl heteroalkanes, process for their preparation and use | BASF Aktiengesellschaft (DE) | 1990-09-12 | — | — | EP | disclosed |
| EP-0386452-A1 | Diphenyl heteroalkyl derivatives, their preparation and medicinal and cosmetic preparations prepared therefrom | BASF Aktiengesellschaft (DE) | 1990-09-12 | — | — | EP | disclosed |
| US-4703110-A | Benzoic acid derivatives having a para substituent which is a substituted phenyl group connected by a linking radical; useful in neoplastic cell differentiation and diagnosis | Shudo, Koichi (JP) | 1987-10-27 | — | — | US | disclosed |
| EP-0170105-A2 | Benzoic acid derivatives | Shudo, Koichi, Prof. Dr. (JP) | 1986-02-05 | — | — | EP | disclosed |
| EP-0137010-A4 | NAPHTHYL OR TETRAHYDRONAPHTHYL-SUBSTITUTED NAPHTHOIC ACID AND DE RIVATES. | STANFORD RES INST INT (US) | 1985-08-12 | — | — | EP | disclosed |
| EP-0137010-A1 | NAPHTHYL OR TETRAHYDRONAPHTHYL-SUBSTITUTED NAPHTHOIC ACID AND DE RIVATES | SRI INTERNATIONAL (US) | 1985-04-17 | — | — | EP | disclosed |
| WO-1984003505-A1 | NAPHTHYL OR TETRAHYDRONAPHTHYL-SUBSTITUTED NAPHTHOIC ACID AND DE RIVATES | STANFORD RES INST INT (US) | 1984-09-13 | — | — | WO | disclosed |
| US-4454341-A | ANTITUMOR, SKIN DISORDERS | SRI INTERNATIONAL (US) | 1984-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250263429-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OPRD1 | RXRA 107/4885RARB 52/4885RXRB 83/4885 |
| US-12552818-B2 | Polycyclic compounds for organic electroluminescent devices | SCO2, ESRRA, LBR | RXRA 344/4885RARB 609/4885RXRB 383/4885 |
| US-20240360114-A1 | FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF | AIFM2, GPX1, GPX4 | RXRA 674/4885RARB 574/4885RXRB 502/4885 |
| US-20240196735-A1 | Organic Compound, Organic Light Emitting Diode and Organic Light Emitting Device Having the Compound | L3MBTL1, TELO2, OCIAD2 | RXRA 1556/4885RARB 1698/4885RXRB 1912/4885 |
| US-12435098-B2 | Heterocyclic compound and organic light-emitting device comprising same | CRKL, AHR, ATXN2L | RXRA 345/4885RARB 2226/4885RXRB 256/4885 |
| US-20230348399-A1 | NOVEL PYRIMIDINE DERIVATIVE AND USE THEREOF | LRRK2, PFKL, PDK3 | RXRA 3013/4885RARB 3113/4885RXRB 2637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.